Skip to main
TBI
TBI logo

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. reported a year-over-year revenue increase of 2%, driven primarily by robust commercial growth, showcasing the strength of its PeopleReady segment. Additionally, the adjusted EBITDA margin improved by 50 basis points year-over-year, reaching 0.7%, indicative of effective strategic cost management. This combination of revenue growth and margin improvement reflects TrueBlue's resilience and operational efficiency, contributing to a positive outlook for the company's financial performance.

Bears say

TrueBlue Inc. experienced a significant decline in its adjusted EBITDA margin, which fell 320 basis points year-over-year to 5.2%, indicating a lack of operating leverage due to declining organic revenues. Notably, revenues from the PeopleReady segment, the company's primary revenue source, dropped by 5% year-over-year, exceeding the anticipated midpoint decline of 3%, reflecting ongoing weakness across various client sectors. Additionally, the company reported an adjusted loss per share of $(0.07) in the second quarter of 2025, further highlighting the firm's financial challenges.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Oct 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.